司爾特(002538.SZ)擬向銀行申請綜合授信不超8億元
格隆匯 1 月 8日丨司爾特(002538.SZ)公佈,公司召開第五屆董事會第十二次(臨時)會議,審議通過《關於向銀行申請綜合授信的議案》。
為滿足公司此次收購貴州路發實業有限公司60%股權支付合同款項等用途,公司擬向中國農業銀行股份有限公司寧國市支行、中國工商銀行股份有限公司寧國支行申請綜合授信業務,授信金額不超過8億元。
上述相關協議尚未實際簽署,具體授信金額、貸款利率和期限以最終簽訂的協議為準。在公司股東會審議通過上述事項後,公司將授權管理層代表公司與上述銀行簽署一切授信有關的協議等法律文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.